120 related articles for article (PubMed ID: 11525649)
21. A protein methyl transferase, PRMT5, selectively blocks oncogenic ras-p21 mitogenic signal transduction.
Chie L; Cook JR; Chung D; Hoffmann R; Yang Z; Kim Y; Pestka S; Pincus MR
Ann Clin Lab Sci; 2003; 33(2):200-7. PubMed ID: 12817625
[TBL] [Abstract][Full Text] [Related]
22. Modulation of vascular smooth muscle cell growth by magnesium-role of mitogen-activated protein kinases.
Touyz RM; Yao G
J Cell Physiol; 2003 Dec; 197(3):326-35. PubMed ID: 14566962
[TBL] [Abstract][Full Text] [Related]
23. PTH regulation of c-Jun terminal kinase and p38 MAPK cascades in intestinal cells from young and aged rats.
Buzzi N; Boland R; de Boland AR
Biogerontology; 2007 Apr; 8(2):189-99. PubMed ID: 17120084
[TBL] [Abstract][Full Text] [Related]
24. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.
Ou YC; Yang CR; Cheng CL; Raung SL; Hung YY; Chen CJ
Eur J Pharmacol; 2007 Jun; 563(1-3):49-60. PubMed ID: 17341418
[TBL] [Abstract][Full Text] [Related]
25. Multiple signaling conduits regulate global differentiation-specific gene expression in PC12 cells.
Marek L; Levresse V; Amura C; Zentrich E; Van Putten V; Nemenoff RA; Heasley LE
J Cell Physiol; 2004 Dec; 201(3):459-69. PubMed ID: 15389548
[TBL] [Abstract][Full Text] [Related]
26. Epigallocatechin-3-gallate selectively inhibits interleukin-1beta-induced activation of mitogen activated protein kinase subgroup c-Jun N-terminal kinase in human osteoarthritis chondrocytes.
Singh R; Ahmed S; Malemud CJ; Goldberg VM; Haqqi TM
J Orthop Res; 2003 Jan; 21(1):102-9. PubMed ID: 12507586
[TBL] [Abstract][Full Text] [Related]
27. c-Jun N-terminal kinase activation in Xenopus laevis eggs and embryos. A possible non-genomic role for the JNK signaling pathway.
Bagowski CP; Xiong W; Ferrell JE
J Biol Chem; 2001 Jan; 276(2):1459-65. PubMed ID: 11029471
[TBL] [Abstract][Full Text] [Related]
28. Plasmid expression of a peptide that selectively blocks oncogenic ras-p21-induced oocyte maturation.
Kovac C; Clie L; Morin J; Friedman FK; Robinson R; Chung DL; Kanovsky M; Flom J; Brandt-Rauf PW; Yamaizumi Z; Michl J; Pincus MR
Cancer Chemother Pharmacol; 2001 Jul; 48(1):9-14. PubMed ID: 11488531
[TBL] [Abstract][Full Text] [Related]
29. An effector peptide from glutathione-S-transferase-pi strongly and selectively blocks mitotic signaling by oncogenic ras-p21.
Chie L; Adler V; Friedman FK; Chung D; Pincus MR
Protein J; 2004 Apr; 23(3):235-8. PubMed ID: 15200055
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of ras-induced oocyte maturation by peptides from ras-p21 and GTPase activating protein (GAP) identified as being effector domains from molecular dynamics calculations.
Friedman FK; Chie L; Chung D; Robinson R; Brandt-Rauf P; Yamaizumi Z; Pincus MR
J Protein Chem; 2002 Jul; 21(5):361-6. PubMed ID: 12206510
[TBL] [Abstract][Full Text] [Related]
31. Pathways for activation of the ras-oncogene-encoded p21 protein.
Pincus MR; Chung D; Dykes DC; Brandt-Rauf P; Weinstein IB; Yamaizumi Z; Nishimura S
Ann Clin Lab Sci; 1992; 22(5):323-42. PubMed ID: 1524403
[TBL] [Abstract][Full Text] [Related]
32. Specificity of inhibition of ras-p21 signal transduction by peptides from GTPase activating protein (GAP) and the son-of sevenless (SOS) ras-specific guanine nucleotide exchange protein.
Chie L; Chung D; Pincus MR
Protein J; 2005 May; 24(4):253-8. PubMed ID: 16283548
[TBL] [Abstract][Full Text] [Related]
33. A peptide from a ras effector-domain blocks ras-dependent cardiac hypertrophy in myocytes.
Deng L; Boujdir M; Tremontano A; Pincus MR; El-Sherif N
Ann Clin Lab Sci; 2009; 39(4):351-60. PubMed ID: 19880762
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of oncogenic and activated wild-type ras-p21 protein-induced oocyte maturation by peptides from the ras-binding domain of the raf-p74 protein, identified from molecular dynamics calculations.
Chung D; Amar S; Glozman A; Chen JM; Friedman FK; Robinson R; Monaco R; Brandt-Rauf P; Yamaizumi Z; Pincus MR
J Protein Chem; 1997 Aug; 16(6):631-5. PubMed ID: 9263125
[TBL] [Abstract][Full Text] [Related]
35. Progesterone but not ras requires MPF for in vivo activation of MAPK and S6 KII: MAPK is an essential conexion point of both signaling pathways.
Carnero A; Jiménez B; Lacal JC
J Cell Biochem; 1994 Aug; 55(4):465-76. PubMed ID: 7962177
[TBL] [Abstract][Full Text] [Related]
36. Bifurcations and chaos in the MAPK signaling cascade.
Zumsande M; Gross T
J Theor Biol; 2010 Aug; 265(3):481-91. PubMed ID: 20435047
[TBL] [Abstract][Full Text] [Related]
37. Oncogenic and activated wild-type ras-p21 proteins induce different isoforms of protein kinase C in mitogenic signal transduction.
Chie L; Qu Y; Chung D; Boutjdir M; Pincus MR
J Protein Chem; 2003 Nov; 22(7-8):625-9. PubMed ID: 14714729
[TBL] [Abstract][Full Text] [Related]
38. Stimulation of mitogen-activated protein kinase by oncogenic Ras p21 in Xenopus oocytes. Requirement for Ras p21-GTPase-activating protein interaction.
Pomerance M; Schweighoffer F; Tocque B; Pierre M
J Biol Chem; 1992 Aug; 267(23):16155-60. PubMed ID: 1322893
[TBL] [Abstract][Full Text] [Related]
39. Evidence that oocyte maturation induced by an oncogenic ras-p21 protein and insulin is mediated by overlapping yet distinct mechanisms.
Chung DL; Joran A; Friedman F; Robinson R; Brandt-Rauf PW; Weinstein IB; Ronai Z; Baskin L; Dykes DC; Murphy RB
Exp Cell Res; 1992 Dec; 203(2):329-35. PubMed ID: 1459198
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of oncogenic and activated wild-type ras-p21 protein-induced oocyte maturation by peptides from the guanine-nucleotide exchange protein, SOS, identified from molecular dynamics calculations. Selective inhibition of oncogenic ras-p21.
Chie L; Chen JM; Friedman FK; Chung DL; Amar S; Michl J; Yamaizumi Z; Brandt-Rauf PW; Pincus MR
J Protein Chem; 1999 Nov; 18(8):875-9. PubMed ID: 10839624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
